Tag #Cbd

Showing 1 to 7 of 7 results

bbc.com

🌐 65% Global Worthiness

Jul 16, 04:12

Trip Drinks Ad Banned for Unauthorised Health Claims

The Advertising Standards Authority (ASA) banned a Trip Drinks advertisement for making unauthorized claims that its cucumber, mint, and magnesium-infused drink could help consumers feel calm and reduce stress and anxiety, violating UK advertising regulations on health benefits for food and beverage...

Trip Drinks Ad Banned for Unauthorised Health Claims

The Advertising Standards Authority (ASA) banned a Trip Drinks advertisement for making unauthorized claims that its cucumber, mint, and magnesium-infused drink could help consumers feel calm and reduce stress and anxiety, violating UK advertising regulations on health benefits for food and beverage...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What specific claims in Trip Drinks' advertisement led to its ban by the Advertising Standards Authority?

Trip Drinks," a UK-based CBD brand, had an advertisement banned by the Advertising Standards Authority (ASA) for making unapproved health claims. The ad, featuring a cucumber and mint drink, asserted the product could induce calmness and reduce stress and anxiety, violating UK advertising regulations on health benefits for food and beverages. The ASA upheld three complaints.

elpais.com

🌐 75% Global Worthiness

Feb 19, 07:08

Cofepris Issues Health Alert Against Illegal Sale of CBD Products in Mexico

Mexico's Cofepris issued a health alert against the illegal sale of CBD products by companies including Paradise (linked to former President Vicente Fox), Doctor CBD, Join't Me, CBDFX, Tryp, Crazy Eats, and Kanabi, for lacking necessary permits, posing health risks due to unregulated production and ...

Cofepris Issues Health Alert Against Illegal Sale of CBD Products in Mexico

Mexico's Cofepris issued a health alert against the illegal sale of CBD products by companies including Paradise (linked to former President Vicente Fox), Doctor CBD, Join't Me, CBDFX, Tryp, Crazy Eats, and Kanabi, for lacking necessary permits, posing health risks due to unregulated production and ...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What prompted Mexico's Cofepris to issue a health alert regarding CBD products?

Mexico's Cofepris issued a health alert due to the illegal sale of cannabidiol (CBD) products by companies like Paradise, Doctor CBD, and others, lacking necessary permits. This poses health risks to consumers, as these products are sold without proper authorization and oversight, potentially causing unintentional intoxication. The alert highlights the risks associated with unregulated CBD products.

forbes.com

🌐 85% Global Worthiness

Jan 10, 22:09

DoorDash Launches Home Delivery of Hemp-Derived CBD and THC Products

DoorDash launched home delivery of hemp-derived CBD and THC products on Thursday, partnering with various companies and utilizing its DashMart platform; this expansion reflects growing consumer demand but raises concerns about regulatory oversight compared to state-regulated cannabis.

DoorDash Launches Home Delivery of Hemp-Derived CBD and THC Products

DoorDash launched home delivery of hemp-derived CBD and THC products on Thursday, partnering with various companies and utilizing its DashMart platform; this expansion reflects growing consumer demand but raises concerns about regulatory oversight compared to state-regulated cannabis.

Progress

36% Bias Score

ShareSaveArticle

Responsible Consumption and Production

12345678

Previous 1 of 8 Next

What is the immediate impact of DoorDash's decision to deliver hemp-derived CBD and THC products?

DoorDash, a prominent gig economy delivery service, launched home delivery of hemp-derived CBD and THC products on Thursday. This expansion includes gummies, beverages, and other popular items, marking a significant step toward mainstreaming cannabis products. The service is initially available in states where such deliveries are legal.

forbes.com

🌐 85% Global Worthiness

Dec 27, 13:09

Single CBD Dose Reduces Alcohol Cravings in AUD Study

A German study found that a single 800mg oral dose of CBD significantly reduced alcohol cravings and lowered activity in the brain's reward center among 28 individuals with alcohol use disorder (AUD), offering the first clinical evidence of CBD's potential in treating AUD.

Single CBD Dose Reduces Alcohol Cravings in AUD Study

A German study found that a single 800mg oral dose of CBD significantly reduced alcohol cravings and lowered activity in the brain's reward center among 28 individuals with alcohol use disorder (AUD), offering the first clinical evidence of CBD's potential in treating AUD.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the key finding of the study regarding CBD's impact on alcohol cravings and brain activity in individuals with AUD?

A new study shows that a single 800mg dose of CBD significantly reduced alcohol cravings and lowered brain reward center activity in people with alcohol use disorder (AUD). This is the first clinical trial demonstrating CBD's potential as an AUD treatment, offering hope for a new approach to managing cravings and relapse.

forbes.com

🌐 75% Global Worthiness

May 27, 16:11

Germany Issues First Tax Stamp for THC-Free CBD Flowers

Sanaleo, a German CBD company, received the first tax stamp for its THC-free CBD flowers this month, marking a legal breakthrough and setting a precedent for the German CBD industry; the product is now subject to tobacco tax and 19% VAT, but the future legal implications remain unclear.

Germany Issues First Tax Stamp for THC-Free CBD Flowers

Sanaleo, a German CBD company, received the first tax stamp for its THC-free CBD flowers this month, marking a legal breakthrough and setting a precedent for the German CBD industry; the product is now subject to tobacco tax and 19% VAT, but the future legal implications remain unclear.

Progress

44% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What is the immediate impact of Germany issuing its first tax stamp for THC-free CBD flowers?

Sanaleo, a German CBD company, received the first-ever tax stamp for its THC-free CBD flowers from German Customs. This decision establishes a precedent, allowing the sale of CBD flowers as industrial hemp and subjecting them to tobacco tax plus 19% VAT. The ruling could reshape the legal framework for CBD products in Germany.

forbes.com

🌐 85% Global Worthiness

Feb 2, 16:10

Cannabis Pouches Emerge as a Multimillion-Dollar Market

Cannadips, a California-based company, created cannabis-infused pouches, mirroring the success of nicotine pouches; generating over $7 million in 2024 revenue and planning to expand to Missouri in 2025 and Kentucky by the end of 2025.

Cannabis Pouches Emerge as a Multimillion-Dollar Market

Cannadips, a California-based company, created cannabis-infused pouches, mirroring the success of nicotine pouches; generating over $7 million in 2024 revenue and planning to expand to Missouri in 2025 and Kentucky by the end of 2025.

Progress

48% Bias Score

ShareSaveArticle

Responsible Consumption and Production

12345678

Previous 1 of 8 Next

What is the market potential for cannabis-infused pouches, considering the explosive growth of the nicotine pouch market?

Cannadips, a cannabis-infused pouch, generated over $7 million in revenue last year and aims to double that in 2025 with expansion into Missouri and Kentucky by the end of 2025. This success mirrors the multibillion-dollar nicotine pouch market, dominated by Zyn with nearly 70% market share and experiencing a 75% shipment volume increase from 2022 to Q3 2024.

dw.com

🌐 85% Global Worthiness

Jan 6, 19:09

Groundbreaking Clinical Trials Anticipated in 2025

In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.

Groundbreaking Clinical Trials Anticipated in 2025

In 2025, several groundbreaking clinical trials will release preliminary data, including a large-scale US dietary study employing AI analysis (8,000+ adults), Oxford University's CBD trial for psychosis (1,000 patients), and research on personalized cancer vaccines.

Progress

12% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the most impactful clinical trials expected in 2025, and what immediate effects will their results have on healthcare?

Several key clinical trials are anticipated to garner significant attention in 2025, focusing on diverse areas such as nutrition, mental health, and cancer treatment. A large-scale US study (8,000+ participants) will yield preliminary results on how diet impacts weight gain, leveraging AI to analyze genetic, lifestyle, and microbiome factors. Oxford University's trial evaluating CBD's efficacy in treating psychosis in 1,000 patients is also expected to release preliminary findings.

Showing 1 to 7 of 7 results